
News – Page 4
-
Juul Takes FDA to Court to Force Document ReleaseElectronic cigarette maker Juul Labs Inc. has filed a lawsuit to force the U.S. Food and Drug…
-
Anxiety vs. Optimism: A Mental Health Q&A With Dr. Michael AdamseClinical psychotherapist and author Dr. Michael Adamse discusses anxiety and offers practical advice for maintaining a sense of optimism and overall…Michelle Llamas, BCPA September 27, 2022
-
Philips Warns Certain CPAP, BiPAP Masks May Cause Serious InjuryPhilips Respironics is warning CPAP and BiPAP users about the risks associated with millions of its respiratory…Michelle Llamas, BCPA September 14, 2022
-
Juul to Pay $438.5 Million to Settle E-Cigarette ProbeWhile denying any wrongdoing, electronic cigarette maker Juul Labs Inc. agreed to pay $438.5 million in a…Michelle Llamas, BCPA September 7, 2022
-
Philips Issues New BiPAP Recall Over Plastic ContaminationPhilips Respironics issued a recall for hundreds of bi-level positive airway pressure devices, also known as BiPAP devices, adding to the…Michelle Llamas, BCPA August 31, 2022
-
Recalled Philips CPAP Devices Among FDA Complaints, Reported DeathsThe U.S. Food and Drug Administration has received tens of thousands of recalled Philips CPAP medical device reports, which include deaths. …Michelle Llamas, BCPA August 31, 2022
-
First Zantac Lawsuit Case Reaches $500,000 SettlementJoseph Bayer, the plaintiff in the first Zantac (ranitidine) trial, has voluntarily dismissed his own case. Reportedly, the dismissal came shortly before trial…Michelle Llamas, BCPA August 30, 2022
-
Camp Lejeune Compensation Signed into LawPresident Joe Biden signed the Camp Lejeune Justice Act of 2022 into law on Wednesday, Aug. 10, finally clearing the path to legal claims…Michelle Llamas, BCPA August 10, 2022
-
Senate Passes PACT Legislation that Includes Camp Lejeune Justice ActWith an assurance that President Joe Biden will quickly sign it into law, the U.S. Senate overwhelmingly passed a bill Tuesday that…Michelle Llamas, BCPA August 3, 2022
Who Am I Calling?
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
(888) 645-1617